Autologous CD22 CAR T Cells in Adults w/ Recurrent or Refractory B Cell Malignancies
Status:
Recruiting
Trial end date:
2034-09-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to test whether CD22-CAR T cells can be successfully
made from immune cells collected from adults with relapsed/refractory B-cell malignancies
(leukemia and lymphoma).